Medpace Holdings, Inc.

Global CRO providing full-service clinical development to biotech, pharma & medical device industries.

MEDP | NDAQ

Overview

Corporate Details

ISIN(s):: N/A
LEI:
Country:: United States of America
Address:: 5375 MEDPACE WAY, 45227 CINCINNATI
Website:: https://investor.medpace.com/
Sector:: Mining and quarrying
Industry:: Mining of non-ferrous metal ores

Description

Medpace Holdings, Inc. is a scientifically-driven, global, full-service clinical contract research organization (CRO). It provides comprehensive Phase I-IV clinical development services to the biotechnology, pharmaceutical, and medical device industries. The company's mission is to accelerate the development of safe and effective medical therapeutics through a disciplined operating approach. Key services include study strategy, clinical trial management, regulatory support, data management, and integrated laboratory services such as central lab, bioanalytical, ECG, and imaging core labs. Medpace leverages therapeutic expertise across major areas including oncology, cardiology, metabolic disease, endocrinology, central nervous system (CNS), and anti-viral/anti-infective diseases.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Quick Filters:

Filters

Filing Type

Language

Start date

End date

Clear

Bulk Actions:

	Date	Filing	Language	Size	Actions
No filings match the current criteria.

Automate Your Workflow. Get a real-time feed of all Medpace Holdings, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for Medpace Holdings, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Request This Data

Need More History? Access decades of standardized financials for Medpace Holdings, Inc. via our API.

Get Historical Data →

Insider Transactions

Date	Insider Name	Position	Type	Shares	Value
No insider transactions recorded for this company.

Peer Companies

Company	Country	Ticker
Bestone.Com Co.,Ltd An online travel agency specializing in domestic and overseas cruise tours and tickets.	Japan	6577
BeyondSpring Inc. Develops innovative immuno-oncology cancer therapies, including a 'pipeline in a drug' asset.	United States of America	BYSI
bioAffinity Technologies, Inc. Develops noninvasive diagnostics for cancer, including an early lung cancer sputum test.	United States of America	BIAF
BIO-FD&C CO.,LTD. Develops plant cell-derived active ingredients for food, drug, and cosmetic industries.	South Korea	251120
BioNexus Gene Lab Corp Develops non-invasive, blood-based RNA tests for early cancer detection and risk assessment.	United States of America	BGLC
Biophytis S.A. Clinical-stage biotech developing drugs for age-related neuromuscular and retinal diseases.	France	ALBPS
BioSenic SA Developing ATO and cell therapies for autoimmune diseases and tissue regeneration.	Belgium	BIOS
BIOTECH Biotech group offering preclinical zebrafish testing & intein tech for human/animal health.	Spain	BST
BiotoxtechCo.,Ltd. A non-clinical CRO providing GLP-compliant safety and toxicity testing for diverse industries.	South Korea	086040
Bolt Biotherapeutics, Inc. Developing immunotherapies that use antibody conjugates to help the immune system destroy cancer.	United States of America	BOLT